Circuit Clinical and Lightship Announce Strategic Merger in Clinical Research
Deal News | Jun 09, 2025 | Globenewswire
Circuit Clinical Solutions Inc. and Lightship Inc. have announced a strategic merger to create a unified entity in the clinical trial delivery industry. This merger is seen as a vital step in consolidating the industry and setting new standards for scale, access, and innovation. The combined organization leverages Lightship's expertise in hybrid trial models and mobile care, alongside Circuit Clinical's strengths in community-based site networks and patient engagement, to offer comprehensive solutions for sponsors, CROs, and patients. Co-CEOs David MacMurchy and Dr. Irfan Khan emphasize the milestone nature of this collaboration and the potential it holds for enhancing clinical research outcomes. Both companies will maintain their existing brand identities in the interim, with a new unified name to be announced later.
Sectors
- Healthcare
- Biotechnology
Geography
- United States – Both Circuit Clinical and Lightship are based in the United States, highlighting the geographical focus of the merger.
Industry
- Healthcare – The merger directly involves advancements in the delivery of clinical trials, an integral component of the healthcare sector.
- Biotechnology – The collaboration impacts the biotechnology sector, particularly in biopharmaceutical research and clinical trials, which is a focus for both companies.
Financials
Participants
Name | Role | Type | Description |
---|---|---|---|
Circuit Clinical Solutions Inc. | Target Company | Company | A research network dedicated to increasing access to clinical trials through a community-based model. |
Lightship Inc. | Bidding Company | Company | A clinical trials service provider focused on increasing access and engagement in clinical trials through hybrid models. |
David MacMurchy | Co-CEO | Person | CEO of Lightship, leading the newly merged entity with Dr. Irfan Khan. |
Dr. Irfan Khan | Co-CEO | Person | CEO of Circuit Clinical, leading the newly merged entity with David MacMurchy. |